BioRegenx Company Description
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally.
The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products.
It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform.
In addition, the company operates a social media content management platform, including its interactive search engine.
Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices.
The company sells its products through a direct selling channel to health professionals and research organizations.
BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
| Country | United States |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 5 |
| CEO | William Resides |
Contact Details
Address: 7407 Ziegler Road Chattanooga, Tennessee 37421 United States | |
| Phone | 866 770 4067 |
| Website | bioregenx.com |
Stock Details
| Ticker Symbol | BRGX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US31772N1000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Diane Bouis | Chief Executive Officer MVHS |
| William Resides | Chief Executive Officer, Interim Chief Financial Officer Chairman, and Executive Director |
| Gary Hennerberg | Secretary |